Delivery Order SPE2DB20D3101-SPE2DB25FRRU2
- Not listed
- The Defense Logistics Agency awarded a $1,942.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for 90 tablets of Januvia 100 mg, a diabetes management medication. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $7,516.23 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Januvia 100 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,546.29 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $2,201.40. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $7,378.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $1,122.20. The award, which is effective through August 19, 2025, was issued as a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $9,081.90 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. This non-set-aside, firm fixed-price contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Januvia 100 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRU2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication, with a ceiling value of $12,790.95. The contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, utilizes firm fixed-price pricing and is non-competitive. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical delivery. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates its established capability to fulfill diverse medical supply requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 8/4/25 |